Angiogenic Response Caused by Oncolytic Herpes Simplex Virus-Induced Reduced Thrombospondin Expression Can Be Prevented by Specific Viral Mutations or by Administering a Thrombospondin-Derived Peptide

Cancer Research - United States
doi 10.1158/0008-5472.can-06-3145
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Scrum-Pox Caused by Herpes Simplex Virus.

BMJ
1979English

Tracheal Pseudo-Tumor Caused by Herpes Simplex Virus

Multidisciplinary Respiratory Medicine
PulmonaryRespiratory Medicine
2013English

Treatment of Human Hepatocellular Carcinoma by the Oncolytic Herpes Simplex Virus G47delta

Cancer Cell International
Cancer ResearchOncologyGenetics
2014English

Immunosurveillance by Antiangiogenesis: Tumor Growth Arrest by T Cell-Derived Thrombospondin-1

Cancer Research
Cancer ResearchOncology
2014English

Latent Herpes Simplex Virus Infections in Sensory Ganglia of Hairless Mice Prevented by Acycloguanosine

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1979English

A Case Report of Myocarditis Combined With Hepatitis Caused by Herpes Simplex Virus

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2018English

Defensins Protect Cells From Infection by Herpes Simplex Virus by Inhibiting Viral Adhesion and Entry

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2004English

Thrombospondin-1 Mediates Distal Tubule Hypertrophy Induced by Glycated Albumin

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2004English

Regulation of Nitric Oxide Signalling by Thrombospondin 1: Implications for Anti-Angiogenic Therapies

Nature Reviews Cancer
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy